Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Phosphorylation N S43 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Phosphorylation N S45 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Phosphorylation N S82 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Phosphorylation N S88 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lung squamous cell carcinoma Phosphorylation C S193 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Ovarian serous cystadenocarcinoma Phosphorylation N S193 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Testicular germ cell tumor Phosphorylation N S217 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Skin cutaneous melanoma Phosphorylation N S232 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Phosphorylation N T303 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Phosphorylation N T303 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Methylation N K307 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Methylation N K307 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K412 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Colon adenocarcinoma Ubiquitination N K472 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Skin cutaneous melanoma Ubiquitination N K502 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Skin cutaneous melanoma Ubiquitination N K509 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Ubiquitination N K595 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Ubiquitination N K595 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Ubiquitination N K596 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Ubiquitination N K596 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K747 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Sarcoma Ubiquitination N K860 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Stomach adenocarcinoma Ubiquitination N K911 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lung adenocarcinoma Ubiquitination N K993 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Renal cell carcinoma Ubiquitination N K1079 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Kidney renal clear cell carcinoma Ubiquitination N K1248 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Kidney renal clear cell carcinoma Phosphorylation N S1258 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Transitional cell carcinoma Ubiquitination N K1357 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Ubiquitination N K1425 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Prostate adenocarcinoma Ubiquitination N K1971 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Skin cutaneous melanoma Ubiquitination N K1998 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Skin cutaneous melanoma Ubiquitination N K2003 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Rectum adenocarcinoma Ubiquitination N K2010 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Rectum adenocarcinoma Ubiquitination N K2016 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Rectum adenocarcinoma Ubiquitination N K2021 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K2136 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Liver cancer Phosphorylation N S2273 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Ubiquitination N K2367 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lung squamous cell carcinoma Ubiquitination N K2367 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Stomach adenocarcinoma Ubiquitination N K2391 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K2426 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Colon adenocarcinoma Ubiquitination N K2426 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Ovarian adenocarcinoma Ubiquitination N K2426 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K2431 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Colon adenocarcinoma Ubiquitination N K2431 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Esophageal adenocarcinoma Ubiquitination N K2431 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Ovarian adenocarcinoma Ubiquitination N K2431 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Prostate adenocarcinoma Ubiquitination N K2431 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Esophageal adenocarcinoma Methylation N R2438 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Ovarian adenocarcinoma Methylation N R2438 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Prostate adenocarcinoma Methylation N R2438 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lung squamous cell carcinoma Ubiquitination N K2529 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Breast invasive carcinoma Ubiquitination N K2628 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K2628 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Skin cutaneous melanoma Ubiquitination N K2740 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Skin cutaneous melanoma Ubiquitination N K2744 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Colon adenocarcinoma Ubiquitination N K2779 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Ubiquitination N K2800 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lymphoid neoplasm diffuse large B-cell lymphoma Acetylation N K2877 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lymphoid neoplasm diffuse large B-cell lymphoma Ubiquitination N K2877 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lymphoid neoplasm diffuse large B-cell lymphoma Ubiquitination N K2878 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Breast invasive carcinoma Ubiquitination N K2915 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Ubiquitination N K2915 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Ubiquitination N K2944 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lung adenocarcinoma Ubiquitination N K2944 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Prostate adenocarcinoma Ubiquitination N K2944 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Ubiquitination N K2948 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lung adenocarcinoma Ubiquitination N K2948 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Prostate adenocarcinoma Ubiquitination N K2948 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Kidney renal papillary cell carcinoma Ubiquitination N K2968 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Kidney renal papillary cell carcinoma Ubiquitination N K2973 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Ubiquitination N K2973 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K3007 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Ubiquitination N K3007 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K3019 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Breast adenocarcinoma Ubiquitination N K3019 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Breast adenocarcinoma Ubiquitination N K3028 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Mesothelioma Ubiquitination N K3028 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Pancreatic adenocarcinoma Ubiquitination N K3028 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lung adenocarcinoma Phosphorylation N Y3158 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lung adenocarcinoma Ubiquitination N K3159 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Ubiquitination N K3171 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Colon adenocarcinoma Ubiquitination N K3202 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K3255 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Cholangiocarcinoma Ubiquitination N K3395 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Skin cutaneous melanoma Ubiquitination N K3517 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Colon adenocarcinoma Methylation N R3559 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Methylation N R3559 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Methylation N R3559 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Colorectal adenocarcinoma Methylation N R3580 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Prostate adenocarcinoma Methylation N R3580 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Ubiquitination N K3592 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K3799 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Ubiquitination N K3799 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Ubiquitination N K3957 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Pancreatic adenocarcinoma Ubiquitination N K3966 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Rectum adenocarcinoma Ubiquitination N K3966 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Stomach adenocarcinoma Ubiquitination N K3966 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Lung squamous cell carcinoma Ubiquitination N K3987 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Prostate adenocarcinoma Ubiquitination N K4005 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Moyamoya disease Phosphorylation N Y4034 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K4115 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Moyamoya disease Ubiquitination N K4115 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Stomach adenocarcinoma Ubiquitination N K4115 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Phosphorylation N S4116 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Moyamoya disease Phosphorylation N S4116 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Stomach adenocarcinoma Phosphorylation N S4116 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Breast adenocarcinoma Phosphorylation N Y4141 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N Y4141 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Ubiquitination N K4158 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Ubiquitination N K4158 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Ubiquitination N K4159 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Ubiquitination N K4159 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Ubiquitination N K4160 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Ubiquitination N K4206 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Breast invasive carcinoma Ubiquitination N K4264 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K4297 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Stomach adenocarcinoma Ubiquitination N K4312 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Ubiquitination N K4335 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Pancreatic adenocarcinoma Ubiquitination N K4335 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Ubiquitination N K4335 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Ubiquitination N K4343 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Pancreatic adenocarcinoma Ubiquitination N K4343 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Ubiquitination N K4343 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Breast invasive carcinoma Ubiquitination N K4349 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Invasive lobular carcinoma Ubiquitination N K4349 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Breast invasive carcinoma Ubiquitination N K4354 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Invasive lobular carcinoma Ubiquitination N K4354 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Moyamoya disease Ubiquitination N K4402 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Head and neck squamous cell carcinoma Ubiquitination N K4622 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Ubiquitination N K4679 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Stomach adenocarcinoma Ubiquitination N K4694 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Ubiquitination N K4694 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Glioblastoma multiforme Ubiquitination N K4707 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Prostate adenocarcinoma Ubiquitination N K4707 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Moyamoya disease Ubiquitination N K4732 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Uterine corpus endometrial carcinoma Ubiquitination N K4732 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Moyamoya disease Ubiquitination N K4739 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Esophageal adenocarcinoma Ubiquitination N K4759 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Rectum adenocarcinoma Ubiquitination N K4759 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Stomach adenocarcinoma Ubiquitination N K4774 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Moyamoya disease Ubiquitination N K4815 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Moyamoya disease Ubiquitination N K4815 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Breast invasive carcinoma Phosphorylation N Y4896 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K4955 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Skin cutaneous melanoma Ubiquitination N K4955 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Stomach adenocarcinoma Ubiquitination N K4955 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K4974 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Phosphorylation N Y4981 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Breast adenocarcinoma Phosphorylation N Y4981 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Prostate adenocarcinoma Ubiquitination N K5095 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Hepatocellular carcinoma Ubiquitination N K5142 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Skin cutaneous melanoma Ubiquitination N K5142 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Stomach adenocarcinoma Ubiquitination N K5142 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Bladder urothelial carcinoma Ubiquitination N K5201 Q63HN8 57674 RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Prostate adenocarcinoma Ubiquitination N K5201